GlaxoSmithKline to buy San Mateo-based Sierra Oncology for $1.9B
April 13, 2022 at 10:31 AM EDT
Glaxo is paying a 39% premium for the rare cancer-focused biotech whose stock has already shot up 82% this year.
|
||||||||||||
![]() |
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
San Anselmo | San Anselmo News | San Anselmo Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|